OrbiMed Capital GP VI, Director: Prelude Therapeutics PRLD Buy · Filed 23/05/24

Trade details

Type: Insider buy
Amount: $4,999,998.75
Shares · price: 869,565 sh · $5.75 a share
Held after: 10,119,756 sh
Stock: Prelude Therapeutics PRLD
Person: OrbiMed Capital GP VIDirector
Trade date: 23/05/22
Filed: 23/05/24
Days to filing: 2 days

7 insiders bought this week

Insiders buying this week: 7 insiders
Holding change: +9.4%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

OrbiMed Capital GP VI's recent trades

OrbiMed Capital GP VIDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
OrbiMed Capital GP VIDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07

OrbiMed Capital GP VI, Director — bought $5M of Prelude Therapeutics PRLD · 869,565 sh @ $5.75 | Whalegun